Why Bristol Myers Squibb Stock Isn't Nearly As Cheap As It Looks
Bristol Myers Squibb has an attractive 4.4% yield, and its 16x P/E is below the pharma average of 24x.
Open original sourceLoading market dashboard
Bristol Myers Squibb has an attractive 4.4% yield, and its 16x P/E is below the pharma average of 24x.
Open original source